In brief, we isolated FGFR2+ fibrocytes from three ESCC patients and transformed these cells into blasticidin (Bsd) resistant-fibrocytes by transfection of Bsd resistance genes. This evidence concerns the gene FGFR2 and esophageal squamous cell carcinoma.